These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16198517)

  • 1. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
    Im JA; Lee JW; Lee HR; Lee DC
    Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC; Cosper P; Nakhuda GS; Lobo RA
    Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
    Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
    Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
    Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
    Kunnari A; Santaniemi M; Jokela M; Karjalainen AH; Heikkinen J; Ukkola O; Kesäniemi YA
    Metabolism; 2008 Nov; 57(11):1509-15. PubMed ID: 18940387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones.
    Laughlin GA; Barrett-Connor E; May S
    Int J Obes (Lond); 2007 Mar; 31(3):457-65. PubMed ID: 16819528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
    Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
    Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
    An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks.
    Gupta P; Harte A; Sturdee DW; Sharma A; Barnett AH; Kumar S; McTernan PG
    Climacteric; 2008 Oct; 11(5):364-72. PubMed ID: 18781480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A; Zhang J; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.
    Manns PJ; Williams DP; Snow CM; Wander RC
    Am J Hum Biol; 2003; 15(1):91-100. PubMed ID: 12552583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women.
    Cagnacci A; Generali M; Pirillo D; Baldassari F; Volpe A
    Climacteric; 2006 Oct; 9(5):388-95. PubMed ID: 17000586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    Cheng SY; Shaw NS; Tsai KS; Chen CY
    J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.